| OEC Omega Therapeutics, Inc.
90708918 13 May 2021 | on 13 Dec 2022
| Pharmaceutical agents affecting DNA structure by targeting DNA structu... Class 005 Class 005 Pharmaceutical Products Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids | | | OMEGA EPIGENOMIC CONTROLLER Omega Therapeutics, Inc.
90171486 10 Sep 2020 | on 29 Nov 2022
| Pharmaceutical agents affecting DNA structure by targeting DNA structu... Class 005 Class 005 Pharmaceutical Products "EPIGENOMIC" | | | OMEGA OMEGA THERAPEUTICS, INC.
87730926 21 Dec 2017 | on 07 Apr 2020
| scientific research; pharmaceutical research services; medical researc... Class 042 Class 042 Computer & Software Services & Scientific Services Color is not claimed as a feature of the mark. | | | OMEGA OMEGA THERAPEUTICS, INC.
87981874 21 Dec 2017 | on 29 Oct 2019
| Pharmaceutical agents affecting DNA structure by targeting DNA structu... Class 005 Class 005 Pharmaceutical Products The mark consists of an incomplete circle superimposed over an incomplete triangle with the circle and triangle joined at the bottom to the left of the word "OMEGA" in a stylized font. | | | OMEGA THERAPEUTICS Omega Therapeutics, Inc.
98377106 26 Jan 2024 | on 26 Nov 2024 | Pharmaceutical agents affecting DNA structure by targeting DNA structu... Class 005 Class 005 Pharmaceutical Products Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids | | | MYCHELANGELO Omega Therapeutics, Inc.
97438108 01 Jun 2022 | on 28 May 2024 | Pharmaceutical agents affecting DNA structure by targeting DNA structu... Class 005 Class 005 Pharmaceutical Products Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease; therapeutic pharmaceutical agents containing MYC inhibiting properties for the treatment of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease Class 042 Class 042 Computer & Software Services & Scientific Services Scientific research; pharmaceutical research services; medical research; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals | | | XQUIS Omega Therapeutics, Inc.
90339915 24 Nov 2020 | on 15 Jan 2024 | Research and development in the field of computational biology, bioinf... Class 005 Class 005 Pharmaceutical Products Pharmaceutical agents affecting DNA structure and/or epigenomic state by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, CNS disorders Class 042 Class 042 Computer & Software Services & Scientific Services Research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals | | | XQUIS-OS Omega Therapeutics, Inc.
90339966 24 Nov 2020 | on 25 Dec 2023 | Research and development in the field of computational biology, bioinf... Class 005 Class 005 Pharmaceutical Products Pharmaceutical agents affecting DNA structure and/or epigenomic state by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, CNS disorders Class 042 Class 042 Computer & Software Services & Scientific Services Research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals | | | OMEGA THERAPEUTICS Omega Therapeutics, Inc.
97342595 01 Apr 2022 | on 29 Nov 2023 | Pharmaceutical agents affecting DNA structure by targeting DNA structu... Class 005 Class 005 Pharmaceutical Products "THERAPEUTICS" | | | PRECISION GENOMIC CONTROL Omega Therapeutics, Inc.
88665753 23 Oct 2019 | on 27 Nov 2023 | Pharmaceutical agents affecting DNA structure by targeting DNA structu... Class 005 Class 005 Pharmaceutical Products Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, multigenic disorders, hepatic disorders and disorders of the CNS, none of the foregoing including omega fatty acids | |